Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Subscribe To Our Newsletter & Stay Updated
